Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Brief
On January 31, 2025, the Korea Health Industry Development Institute (KHIDI) issued an update regarding "New path opens for sporadic Alzheimer's treatment". Researchers from a Korean university successfully identified a molecular mechanism to control amyloid beta, a protein fragment linked to Alzheimer's disease, and presented a new therapeutic approach for sporadic Alzheimer's.
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
